These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 4625697)

  • 21. [Furosemide--pharmacokinetics in geriatric patients with multimorbidity].
    Neubig E; Mühlberg W; Platt D
    Z Gerontol; 1984; 17(5):251-60. PubMed ID: 6523981
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cephalothin levels in human bile.
    Ram MD; Watanatittan S
    Arch Surg; 1974 Feb; 108(2):187-9. PubMed ID: 4810525
    [No Abstract]   [Full Text] [Related]  

  • 23. [Administration of cephalothin and cephloridine in uremic patients with hemodialysis].
    Takayasu H; Kitagawa R; Miyamura R; Koiso K; Kano S
    Saishin Igaku; 1971 Jun; 26(6):1173-7. PubMed ID: 5098182
    [No Abstract]   [Full Text] [Related]  

  • 24. [Serum levels of cephalothin, ampicillin and cloxacillin in children with and without renal failure].
    Sieniawaska M; Wróblewska-Kałuzewska M; Wierzbowska-Lange B; Korniszewska J; Kaźmirowska Z; Suska A; Janecki J
    Pediatr Pol; 1974 Feb; 49(2):133-41. PubMed ID: 4549872
    [No Abstract]   [Full Text] [Related]  

  • 25. Measurement of the kidney function in patients with rheumatoid arthritis: plasma cystatin C versus 51Cr-EDTA clearance.
    Karstila K; Harmoinen AP; Lehtimäki TJ; Korpela MM; Mustonen JT; Saha HH
    Nephron Clin Pract; 2008; 108(4):c284-90. PubMed ID: 18434750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interstitial diffusion and accumulation of cephalothin according to various modes of intermittent administration to rabbits.
    Carbon C; Chau NP; Contrepois A; Lamotte-Barrillon S
    J Antimicrob Chemother; 1978 Jul; 4(4):349-53. PubMed ID: 690035
    [No Abstract]   [Full Text] [Related]  

  • 27. The fate of parenteral cephalothin and related antibiotics in the rat. The nature of a minor long-lived metabolite.
    Sullivan HR; McMahon RE; Heiney RE
    J Antibiot (Tokyo); 1971 Jun; 24(6):375-82. PubMed ID: 5091214
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacokinetics of glucarpidase in subjects with normal and impaired renal function.
    Phillips M; Smith W; Balan G; Ward S
    J Clin Pharmacol; 2008 Mar; 48(3):279-84. PubMed ID: 18192538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pharmacology of cephalothin in the biliary tract of humans.
    Mendelson J; Portnoy J; Sigman H; Dick V
    Antimicrob Agents Chemother; 1974 Dec; 6(6):659-65. PubMed ID: 4451341
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Radioactive chromium-ethylenediaminetetraacetic acid for determination of glomerular filtration rate in rabbits.
    Tvedegaard E; Kamstrup O
    Lab Anim Sci; 1981 Dec; 31(6):688-92. PubMed ID: 6806534
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Renal clearance of 51Cr-EDTA-complex.
    Aurell M
    Strahlentherapie Sonderb; 1968; 67():420-4. PubMed ID: 4976018
    [No Abstract]   [Full Text] [Related]  

  • 32. [Does the mathematical analysis of changes in serum creatinine and clearance permit a judgment on the prognosis of kidney diseases or the effectivity of therapy?].
    Wichmann HE; Vlaho M; Peitz R; Sieberth HG
    Verh Dtsch Ges Inn Med; 1978; (84):1272-75. PubMed ID: 741946
    [No Abstract]   [Full Text] [Related]  

  • 33. [Studies on the biliary excretion of sodium cephalothin (CET) in human. I (author's transl)].
    Tera S
    Jpn J Antibiot; 1975 Apr; 28(2):179-87. PubMed ID: 1152276
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinical pharmacology of cephalexin administered intravenously.
    De Maine JB; Kirby WM
    Antimicrob Agents Chemother (Bethesda); 1970; 10():190-4. PubMed ID: 5521336
    [No Abstract]   [Full Text] [Related]  

  • 35. Pharmacokinetics in renally impaired subjects of NXY-059, a nitrone-based, free-radical trapping agent developed for the treatment of acute stroke.
    Strid S; Borgå O; Edenius C; Jostell KG; Odergren T; Weil A
    Eur J Clin Pharmacol; 2002 Sep; 58(6):409-15. PubMed ID: 12242600
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Study of the impact of tetanic crises on renal function (estimated by clearance of creatinine, inulin and para-aminohippuric acid)].
    Fontenaille C; Dureux JB; Boulangé M
    J Urol Nephrol (Paris); 1968 Dec; 74(12):989-95. PubMed ID: 5714752
    [No Abstract]   [Full Text] [Related]  

  • 37. Pharmacokinetics of a new cephalosporin, cephacetrile, in patients with normal and impaired renal function.
    Westenfelder SR; Naber KG; Madsen PO
    Arzneimittelforschung; 1974 Sep; 24(9b):1481-5. PubMed ID: 4479808
    [No Abstract]   [Full Text] [Related]  

  • 38. [Clinical indications for clearance determination].
    Reubi F
    Praxis; 1967 Jun; 56(23):805-6. PubMed ID: 5632968
    [No Abstract]   [Full Text] [Related]  

  • 39. [Dosage of intravenously administered dicloxacillin in normal and reduced renal function].
    Höffler D; Koeppe P; Schaefer K; Opitz A
    Arzneimittelforschung; 1969 Sep; 19(9):1508-13. PubMed ID: 5394523
    [No Abstract]   [Full Text] [Related]  

  • 40. The pharmacology of cefamandole in patients with reduced renal function.
    Czerwinski AW; Pederson JA
    Scand J Infect Dis Suppl; 1980; suppl 25():45-8. PubMed ID: 6937951
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.